The Los Angeles Times reports, “In an action that could roil a patent market worth billions of dollars, the U.S. patent office has reopened the thorny question of who invented a key CRISPR gene editing technology first—the University of California or the Broad Institute of MIT and Harvard.”
Referencing client The University of California, Berkeley, Director Eldora L. Ellison, Ph.D. is quoted in the coverage saying, “We expected that the office would declare an interference, so they could determine who was first to invent the use of CRISPR in eukaryotes.”
Related Professionals
Related Industries
Related Services
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates